HomeCompareKTRA vs GIS

KTRA vs GIS: Dividend Comparison 2026

KTRA yields 928.51% · GIS yields 6.55%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KTRA wins by $9.224768444729638e+22M in total portfolio value
10 years
KTRA
KTRA
● Live price
928.51%
Share price
$0.22
Annual div
$2.00
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9.224768444729638e+22M
Annual income
$92,228,602,655,528,430,000,000,000,000.00
Full KTRA calculator →
GIS
GIS
● Live price
6.55%
Share price
$37.11
Annual div
$2.43
5Y div CAGR
22.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$79.2K
Annual income
$16,311.42
Full GIS calculator →

Portfolio growth — KTRA vs GIS

📍 KTRA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKTRAGIS
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KTRA + GIS cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KTRA pays
GIS pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KTRA
Annual income on $10K today (after 15% tax)
$78,922.93/yr
After 10yr DRIP, annual income (after tax)
$78,394,312,257,199,170,000,000,000,000.00/yr
GIS
Annual income on $10K today (after 15% tax)
$556.59/yr
After 10yr DRIP, annual income (after tax)
$13,864.71/yr
At 15% tax rate, KTRA beats the other by $78,394,312,257,199,170,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KTRA + GIS for your $10,000?

KTRA: 50%GIS: 50%
100% GIS50/50100% KTRA
Portfolio after 10yr
$4.612384222364819e+22M
Annual income
$46,114,301,327,764,220,000,000,000,000.00/yr
Blended yield
99.98%
📊

Analyst Conviction Gap

Where Wall Street is split right now

KTRA
Analyst Ratings
3
Buy
1
Hold
Consensus: Buy
Altman Z
-7.7
Piotroski
1/9
GIS
Analyst Ratings
9
Buy
19
Hold
6
Sell
Consensus: Hold
Price Target
$47.42
+27.8% upside vs current
Range: $35.00 — $63.00
Altman Z
2.2
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KTRA buys
0
GIS buys
0
No recent congressional trades found for KTRA or GIS in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKTRAGIS
Forward yield928.51%6.55%
Annual dividend / share$2.00$2.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%22.8%
Portfolio after 10y$9.224768444729638e+22M$79.2K
Annual income after 10y$92,228,602,655,528,430,000,000,000,000.00$16,311.42
Total dividends collected$9.22464356544689e+22M$51.1K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold

Year-by-year: KTRA vs GIS ($10,000, DRIP)

YearKTRA PortfolioKTRA Income/yrGIS PortfolioGIS Income/yrGap
1← crossover$196,401$185,701.02$11,504$804.11+$184.9KKTRA
2$7,027,321$6,817,172.01$13,371$1,061.65+$7.01MKTRA
3$463,447,509$455,928,275.47$15,723$1,416.15+$463.43MKTRA
4$56,698,112,446$56,202,223,611.72$18,735$1,911.16+$56698.09MKTRA
5$12,912,579,631,755$12,851,912,651,437.11$22,660$2,613.51+$12912579.61MKTRA
6$5,484,711,654,366,623$5,470,895,194,160,645.00$27,874$3,627.81+$5484711654.34MKTRA
7$4,349,424,397,994,440,700$4,343,555,756,524,268,500.00$34,947$5,121.52+$4349424397994.41MKTRA
8$6,442,930,094,194,810,000,000$6,438,276,210,088,955,000,000.00$44,762$7,369.21+$6442930094194810.00MKTRA
9$17,833,450,250,405,050,000,000,000$17,826,556,315,204,260,000,000,000.00$58,728$10,832.80+$17833450250405050368.00MKTRA
10$92,247,684,447,296,380,000,000,000,000$92,228,602,655,528,430,000,000,000,000.00$79,151$16,311.42+$9.224768444729638e+22MKTRA

KTRA vs GIS: Complete Analysis 2026

KTRAStock

Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a photodynamic therapy for the treatment of cutaneous metastatic breast cancer. The company has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China. The company was formerly known as DelMar Pharmaceuticals, Inc. and changed its name to Kintara Therapeutics, Inc. in August 2020. Kintara Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Diego, California.

Full KTRA Calculator →

GISConsumer Staples

General Mills, Inc. manufactures and markets branded consumer foods worldwide. The company operates in five segments: North America Retail; Convenience Stores & Foodservice; Europe & Australia; Asia & Latin America; and Pet. It offers ready-to-eat cereals, refrigerated yogurt, soup, meal kits, refrigerated and frozen dough products, dessert and baking mixes, bakery flour, frozen pizza and pizza snacks, snack bars, fruit and salty snacks, ice cream, nutrition bars, wellness beverages, and savory and grain snacks, as well as various organic products, including frozen and shelf-stable vegetables. It also supplies branded and unbranded food products to the North American foodservice and commercial baking industries; and manufactures and markets pet food products, including dog and cat food. The company markets its products under the Annie's, Betty Crocker, Bisquick, Blue Buffalo, Blue Basics, Blue Freedom, Bugles, Cascadian Farm, Cheerios, Chex, Cinnamon Toast Crunch, Cocoa Puffs, Cookie Crisp, EPIC, Fiber One, Food Should Taste Good, Fruit by the Foot, Fruit Gushers, Fruit Roll-Ups, Gardetto's, Go-Gurt, Gold Medal, Golden Grahams, Häagen-Dazs, Helpers, Jus-Rol, Kitano, Kix, Lärabar, Latina, Liberté, Lucky Charms, Muir Glen, Nature Valley, Oatmeal Crisp, Old El Paso, Oui, Pillsbury, Progresso, Raisin Nut Bran, Total, Totino's, Trix, Wanchai Ferry, Wheaties, Wilderness, Yoki, and Yoplait trademarks. It sells its products directly, as well as through broker and distribution arrangements to grocery stores, mass merchandisers, membership stores, natural food chains, e-commerce retailers, commercial and noncommercial foodservice distributors and operators, restaurants, convenience stores, and pet specialty stores, as well as drug, dollar, and discount chains. The company operates 466 leased and 392 franchise ice cream parlors. General Mills, Inc. was founded in 1866 and is headquartered in Minneapolis, Minnesota.

Full GIS Calculator →
📬

Get this KTRA vs GIS comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KTRA vs SCHDKTRA vs JEPIKTRA vs OKTRA vs KOKTRA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.